SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments -- Ignore unavailable to you. Want to Upgrade?

To: Peter V who wrote (2818)9/10/1998 12:41:00 PM
From: Kevin Podsiadlik  Respond to of 18998
 
Imbalance usually means we had someone dump big time, and they needed some time for enough buy orders to come in to pick it all up. Basically it's just a measure to maintain an orderly market.



To: Peter V who wrote (2818)9/10/1998 12:49:00 PM
From: Cube  Respond to of 18998
 
Bob,

Same can happen on the up side. Normally with a biotech that gets FDA approval, there can be so many buyers at say $50 per share, but because of the good news, absolutely nobody is willing to sell for anything under $70 per share. This imbalance can halt a stock for quite a while til matters get sorted out. It is almost always a signal of a major up or down move when the stock trades again.

Cube


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News